Enhancing Low-Intensity Coaching in Parent Implemented Early Start Denver Model Intervention for Early Autism: A Randomized Comparison Treatment Trial.


Journal

Journal of autism and developmental disorders
ISSN: 1573-3432
Titre abrégé: J Autism Dev Disord
Pays: United States
ID NLM: 7904301

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 12 9 2018
medline: 12 4 2019
entrez: 12 9 2018
Statut: ppublish

Résumé

Short-term low intensity parent implemented intervention studies for toddlers with autism spectrum disorder (ASD) have found it difficult to demonstrate significantly improved developmental scores or autism severity compared to community treatment. We conducted a randomized comparative intent-to-treat study of a parent implemented intervention to (1) test the effects of an enhanced version on parent and child learning, and (2) evaluate the sensitivity to change of proximal versus distal measures of child behavior. We randomized 45 children with ASD, 12-30 months of age, into one of two versions of parent-implemented Early Start Denver Model (P-ESDM), the basic model, in which we delivered 1.5 h of clinic-based parent coaching weekly, and an enhanced version that contained three additions: motivational interviewing, multimodal learning tools, and a weekly 1.5-h home visit. We delivered the intervention for 12 weeks and measured child and parent change frequently in multiple settings. We found a time-by-group interaction: parents in the enhanced group demonstrated significantly greater gains in interaction skills than did parents in the non-enhanced group. Both interventions were associated with significant developmental acceleration; however, child outcomes did not differ by group. We found a significant relationship between degree of change in parental interaction skill and rate of children's improvement on our proximal measure. Parents in both groups reported satisfaction with the intervention. These findings suggest that parent skills improved more in the enhanced group than the comparison group. Children in the two groups showed similar improvements. Rate of individual parent learning was associated with greater individual child progress on a measure quite proximal to the treatment, though not on standardized assessments.

Identifiants

pubmed: 30203308
doi: 10.1007/s10803-018-3740-5
pii: 10.1007/s10803-018-3740-5
doi:

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

632-646

Subventions

Organisme : Autism Speaks
ID : 8089
Pays : United States
Organisme : Autism Speaks
ID : 8376
Pays : United States

Références

Monogr Soc Res Child Dev. 1999;64(1):1-114
pubmed: 10412222
J Autism Dev Disord. 2001 Apr;31(2):131-44
pubmed: 11450812
J Autism Dev Disord. 2002 Apr;32(2):77-89
pubmed: 12058846
J Autism Dev Disord. 2006 Aug;36(6):723-32
pubmed: 16614790
Arch Gen Psychiatry. 2006 Jun;63(6):694-701
pubmed: 16754843
J Autism Dev Disord. 2009 May;39(5):693-705
pubmed: 19082876
Autism. 2009 Jan;13(1):93-115
pubmed: 19176579
Pediatrics. 2010 Jan;125(1):e17-23
pubmed: 19948568
J Autism Dev Disord. 2010 Sep;40(9):1045-56
pubmed: 20145986
J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):1052-65
pubmed: 23021480
Autism Res Treat. 2012;2012:121878
pubmed: 23227334
J Autism Dev Disord. 2014 Feb;44(2):353-65
pubmed: 23838727
Clin Psychol Rev. 2014 Feb;34(1):73-86
pubmed: 24424351
Res Dev Disabil. 2014 Dec;35(12):3632-44
pubmed: 25241118
Infant Behav Dev. 2014 Nov;37(4):711-21
pubmed: 25260191
J Child Psychol Psychiatry. 2015 Aug;56(8):884-92
pubmed: 25346345
Pediatrics. 2014 Dec;134(6):1084-93
pubmed: 25367544
J Consult Clin Psychol. 2015 Jun;83(3):554-63
pubmed: 25822242
J Autism Dev Disord. 2015 Sep;45(9):2889-98
pubmed: 25911977
Autism Res. 2016 Aug;9(8):899-912
pubmed: 26688077
Biometrics. 1980 Mar;36(1):81-90
pubmed: 7370375
Am J Ment Retard. 1993 Jan;97(4):359-72; discussion 373-91
pubmed: 8427693

Auteurs

S J Rogers (SJ)

University of California Davis MIND Institute, Sacramento, CA, USA. sjrogers@ucdavis.edu.

A Estes (A)

University of Washington, Seattle, WA, USA.

L Vismara (L)

University of California Davis MIND Institute, Sacramento, CA, USA.
Emory University, Atlanta, GA, USA.

J Munson (J)

University of Washington, Seattle, WA, USA.

C Zierhut (C)

University of California Davis MIND Institute, Sacramento, CA, USA.

J Greenson (J)

University of Washington, Seattle, WA, USA.

G Dawson (G)

Duke University, Durham, NC, USA.

M Rocha (M)

University of California Davis MIND Institute, Sacramento, CA, USA.

C Sugar (C)

University of California, Los Angeles, Los Angeles, CA, USA.

D Senturk (D)

University of California, Los Angeles, Los Angeles, CA, USA.

F Whelan (F)

University of California, Los Angeles, Los Angeles, CA, USA.

M Talbott (M)

University of California Davis MIND Institute, Sacramento, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH